University of Cincinnati

09/05/07, Cincinnati—New insights into the role of estrogen receptor in mammary gland development may help scientists better understand the molecular origin of breast cancer, according to new research from the University of Cincinnati (UC).

About a decade ago, U.S. scientists at the National Institutes of Health (NIH) developed a standard estrogen receptor (ER) gene knock-out mouse model to study the estrogen receptor’s role in human diseases.    » read more »

08/30/07, Cincinnati — Patients who want to eliminate unsightly hair, broken blood vessels or signs of sun damage can now do so with one medically based skin treatment system.

Known as StarLux, this pulsed light system uses specialized handpieces to deliver targeted wavelengths of light effective for treating specific layers of skin.    » read more »

09/01/07, Cincinnati — A common molecular pathway could help physicians predict which lung cancer patients will benefit from chemotherapy drugs, according to new research from a multidisciplinary team at the University of Cincinnati (UC).

Known as the retinoblastoma (RB) tumor suppressor, this fundamental molecule regulates cell proliferation in the body. Research has shown that the RB pathway is either entirely inactive or altered in most human cancers. Scientists are beginning to use its actions as a “biomarker” for how tumors will respond to different therapies.    » read more »

09/04/07, CINCINNATI—University of Cincinnati (UC) scientists have received grants totaling $180,000 for research into Parkinson’s disease.

The funding was provided by the Colorado-based Davis Phinney Foundation,whose October 2006 Sunflower Revolution Gala and bike ride in Cincinnati raised $300,000 for Parkinson’s research. All the UC recipients are affiliated with the Neuroscience Institute at the University of Cincinnati and University Hospital,    » read more »